{"id":"NCT01473524","sponsor":"Intercept Pharmaceuticals","briefTitle":"Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis","officialTitle":"A Phase 3, Double-Blind, Placebo-Controlled Trial and Long-Term Safety Extension of Obeticholic Acid in Patients With Primary Biliary Cirrhosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01","primaryCompletion":"2013-12","completion":"2018-12-17","firstPosted":"2011-11-17","resultsPosted":"2017-02-13","lastUpdate":"2021-05-06"},"enrollment":217,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Primary Biliary Cirrhosis"],"interventions":[{"type":"DRUG","name":"Obeticholic Acid (OCA)","otherNames":["6Î±-ethyl chenodeoxycholic acid (6-ECDCA)","INT-747"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"DB OCA 5-10 mg","type":"EXPERIMENTAL"},{"label":"DB OCA 10 mg","type":"EXPERIMENTAL"},{"label":"DB Placebo","type":"PLACEBO_COMPARATOR"},{"label":"LTSE OCA","type":"EXPERIMENTAL"}],"summary":"The main objectives of the study were to assess the effects of Obeticholic Acid (OCA) on serum alkaline phosphatase (ALP) and total bilirubin, together as a composite endpoint and on safety in participants with primary biliary cirrhosis (PBC).","primaryOutcome":{"measure":"DB Phase: Composite Endpoint Alkaline Phosphatase (ALP) And Total Bilirubin, 10 mg OCA Versus Placebo","timeFrame":"DB Month 12","effectByArm":[{"arm":"DB OCA 10 mg","deltaMin":47,"sd":null},{"arm":"DB Placebo","deltaMin":10,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":59,"countries":["United States","Australia","Austria","Belgium","Canada","France","Germany","Italy","Netherlands","Poland","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["19554543","27532829","30922873","33319187","31606455","25543678"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":70},"commonTop":["Pruritus","Fatigue","Nasopharyngitis","Headache","Urinary tract infection"]}}